Classification of the thoroughness of mediastinal staging of lung cancer

Chest

Volumn 137, Issue 2, 2010, Pages 436-442

  Detterbeck, Frank ^a   Puchalski, Jonathan ^a   Rubinowitz, Ami ^a   Cheng, David ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGOGRAPHY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPHADENECTOMY; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; NEEDLE BIOPSY; NOTE; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TRANSBRONCHIAL ASPIRATION; TRANSTHORACIC ASPIRATION;

EID: 76749134260     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-1378     Document Type: Note

References (62)

1. Silvestri GA, Gould MK, Margolis ML, et al; American College of Chest Physicians. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 suppl):178S-201S.
2. Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA; American College of Chest Physicians. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 suppl):202S-220S.
3. Detterbeck FC. Integration of mediastinal staging techniques for lung cancer. Semin Thorac Cardiovasc Surg. 2007;19(3):217-224.
4. Fry WA, Menck HR, Winchester DP. The National Cancer Data Base report on lung cancer. Cancer. 1996;77(9):1947-1955.
5. Little AG, Rusch VW, Bonner JA, et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg. 2005;80(6):2051-2056.
6. Little AG, Gay EG, Gaspar LE, Stewart AK. National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer. 2007;57(3):253-260.
7. van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet. 2002;359(9315):1388-1393.
8. Tsang GMK, Watson DCT. The practice of cardiothoracic surgeons in the perioperative staging of non-small cell lung cancer. Thorax. 1992;47(1):3-5.
9. Farjah F, Flum DR, Ramsey SD, Heagerty PJ, Symons RG, Wood DE. Multi-modality mediastinal staging for lung cancer among medicare beneficiaries. J Thorac Oncol. 2009;4(3):355-363.
10. Detterbeck F. What is quality and does it matter? J Thorac Oncol. 2009;4(3):279-280.
11. Hsu L-H, Liu C-C, Ko J-S. Education and experience improve the performance of transbronchial needle aspiration: a learning curve at a cancer center. Chest. 2004;125(2):532-540.
12. van Vliet EP, Eijkemans MJ, Kuipers EJ, et al. A comparison between low-volume referring regional centers and a high-volume referral center in quality of preoperative metastasis detection in esophageal carcinoma. Am J Gastroenterol. 2006;101(2):234-242.
13. Haponik EF, Cappellari JO, Chin R, et al. Education and experience improve transbronchial needle aspiration performance. Am J Respir Crit Care Med. 1995;151(6):1998-2002.
14. Rodríguez de Castro F, Díaz López F, Serdà GJ, López AR, Gilart JF, Cabrera Navarro P. Relevance of training in transbronchial fine-needle aspiration technique. Chest. 1997;111(1):103-105.
15. Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system. Chest. 2009;136(1):260-271.
16. De Leyn P, Lardinois D, Van Schil PE, et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg. 2007;32(1):1-8.
17. Zieliñski M. Transcervical extended mediastinal lymphadenectomy: results of staging in two hundred fifty-six patients with non-small cell lung cancer. J Thorac Oncol. 2007;2(4):370-372.
18. Kuzdzał J, Zieliñski M, Papla B, et al. Transcervical extended mediastinal lymphadenectomy - the new operative technique and early results in lung cancer staging. Eur J Cardiothorac Surg. 2005;27(3):384-390.
19. Witte B, Wolf M, Huertgen M, Toomes H. Video-assisted mediastinoscopic surgery: clinical feasibility and accuracy of mediastinal lymph node staging. Ann Thorac Surg. 2006;82(5):1821-1827.
20. Lee HS, Lee GK, Lee H-S, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station? Chest. 2008;134(2):368-374.
21. Chin R Jr, McCain TW, Lucia MA, et al. Transbronchial needle aspiration in diagnosing and staging lung cancer: how many aspirates are needed? Am J Respir Crit Care Med. 2002;166(3):377-381.
22. Diacon AH, Schuurmans MM, Theron J, et al. Transbronchial needle aspirates: how many passes per target site? Eur Respir J. 2007;29(1):112-116.
23. Baram D, Garcia RB, Richman PS. Impact of rapid on-site cytologic evaluation during transbronchial needle aspiration. Chest. 2005;128(2):869-875.
24. Davenport RD. Rapid on-site evaluation of transbronchial aspirates. Chest 1990;98(1):59-61.
25. Klapman JB, Logrono R, Dye CE, Waxman I. Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol. 2003;98(6):1289-1294.
26. Diacon AH, Schuurmans MM, Theron J, et al. Utility of rapid on-site evaluation of transbronchial needle aspirates. Respiration. 2005;72(2):182-188.
27. Harrow EM, Abi-Saleh W, Blum J, et al. The utility of transbronchial needle aspiration in the staging of bronchogenic carcinoma. Am J Respir Crit Care Med. 2000;161(2 pt 1):601-607.
28. Fischer BMB, Mortensen J, Højgaard L. Positron emission tomo graphy in the diagnosis and staging of lung cancer: a systematic, quantitative review. Lancet Oncol. 2001;2(11):659-666.
29. Vansteenkiste JF, Stroobants SG, De Leyn PR, et al; Leuven Lung Cancer Group. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable nonsmall cell lung cancer: a prospective analysis of 50 cases. Chest. 1997;112(6):1480-1486.
30. Vansteenkiste JF, Stroobants SG, Dupont PJ, et al. FDGPET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group. Eur J Nucl Med. 1998;25(11):1495-1501.
31. Antoch G, Saoudi N, Kuehl H, et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol. 2004;22(21):4357-4368.
32. Lardinois D, Weder W, Hany TF, et al. Staging of nonsmall-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003;348(25):2500-2507.
33. Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg. 2004;78(3):1017-1023.
34. Smulders SA, Gundy CM, van Lingen A, Comans EF, Smeenk FW, Hoekstra OS; Study Group of Clinical PET. Observer variation of 2-deoxy-2-[F-18]fluoro-D- glucose-positron emission tomography in mediastinal staging of non-small cell lung cancer as a function of experience, and its potential clinical impact. Mol Imaging Biol. 2007;9(5):318-322.
35. Brehmer B. In one word: not from experience. Acta Psychol (Amst). 1980;45(1-3):223-241.
36. Hadi M, Bacharach SL, Whatley M, et al. Glucose and insulin variations in patients during the time course of a FDGPET study and implications for the "glucose-corrected" SUV. Nucl Med Biol. 2008;35(4):441-445.
37. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology. 1991;178(3):705-713.
38. Detterbeck FC, Jones DR, Parker LA Jr. Intrathoracic staging. In: Detterbeck FC, Rivera MP, Socinski MA, et al, eds. Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician. Philadelphia: W.B. Saunders; 2001:73-93.
39. Lewis JW Jr, Pearlberg JL, Beute GH, et al. Can computed tomography of the chest stage lung cancer? Yes and no. Ann Thorac Surg. 1990;49(4):591-595.
40. Staples CA, Müller NL, Miller RR, Evans KG, Nelems B. Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy. Radiology. 1988;167(2):367-372.
41. Dales RE, Stark RM, Raman S. Computed tomography to stage lung cancer. Approaching a controversy using metaanalysis. Am Rev Respir Dis. 1990;141(5 pt 1):1096-1101.
42. Kozuka T, Tomiyama N, Johkoh T, et al. Coronal multiplanar reconstruction view from isotropic voxel data sets obtained with multidetector-row CT: assessment of detection and size of mediastinal and hilar lymph nodes. Radiat Med. 2003;21(1):23-27.
43. Takahashi M, Nitta N, Takazakura R, Nagatani Y, Ushio N, Murata K. Detection of mediastinal and hilar lymph nodes by 16-row MDCT: is contrast material needed? Eur J Radiol. 2008;66(2):287-291.
44. Haramati LB, Cartagena AM, Austin JH. CT evaluation of mediastinal lymphadenopathy: noncontrast 5 mm vs postcontrast 10 mm sections. J Comput Assist Tomogr. 1995;19(3):375-378.
45. Patz EF Jr, Erasmus JJ, McAdams HP, et al. Lung cancer staging and management: comparison of contrast-enhanced and nonenhanced helical CT of the thorax. Radiology. 1999;212(1):56-60.
46. Cascade PN, Gross BH, Kazerooni EA, et al. Variability in the detection of enlarged mediastinal lymph nodes in staging lung cancer: a comparison of contrast-enhanced and unenhanced CT. AJR Am J Roentgenol. 1998;170(4):927-931.
47. Watanabe Y, Shimizu J, Oda M, et al. Aggressive surgical intervention in N2 non-small cell cancer of the lung. Ann Thorac Surg. 1991;51(2):253-261.
48. Lardinois D, De Leyn P, Van Schil P, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg. 2006;30(5):787-792.
49. Detterbeck F. What to do with "surprise" N2?: intraoperative management of patients with non-small cell lung cancer. J Thorac Oncol. 2008;3(3):289-302.
50. Gaer JAR, Goldstraw P. Intraoperative assessment of nodal staging at thoracotomy for carcinoma of the bronchus. Eur J Cardiothorac Surg. 1990;4(4):207-210.
51. Bollen ECM, van Duin CJ, Theunissen PHMH, vt Hof-Grootenboer BE, Blijham GH. Mediastinal lymph node dissection in resected lung cancer: morbidity and accuracy of staging. Ann Thorac Surg. 1993;55(4):961-966.
52. Allen MS, Darling GE, Pechet TTV, et al; ACOSOG Z0030 Study Group. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006;81(3):1013-1019.
53. Izbicki JR, Passlick B, Pantel K, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial. Ann Surg. 1998;227(1):138-144.
54. Sugi K, Nawata K, Fujita N, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-smallcell lung cancer less than 2 cm in diameter. World J Surg. 1998;22(3):290-294.
55. Wu Y, Huang ZF, Wang SY, Yang XN, Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer. 2002;36(1):1-6.
56. Izbicki JR, Passlick B, Karg O, et al. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg. 1995;59(1):209-214.
57. Sakao Y, Miyamoto H, Yamazaki A, et al. The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy. Eur J Cardiothorac Surg. 2006;30(3):543-547.
58. Cheng D, Downey RJ, Kernstine K, et al. Video-assisted thoracic surgery in lung cancer resection: a meta-analysis and systematic review of controlled trials. Innovations. 2007;2(6):261-292.
59. Robinson L, Ruckdeschel J, Wagner HJ, et al; American College of Chest Physicians. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based guidelines (2nd edition). Chest. 2007;132(3 Suppl):243S-265S.
60. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K; American College of Chest Physicians. Treatment of nonsmall cell lung cancer stage I and stage II: ACCP evidencebased clinical practice guidelines (2nd edition). Chest. 2007;132(3 suppl):234S-242S.
61. Frencher SK Jr, Ryoo JJ, Ko CY. Emerging importance of certification: volume, outcomes, and regionalization of care. J Surg Oncol. 2009;99(3):131-132.
62. Sundaresan S, Langer B, Oliver T, Schwartz F, Brouwers M, Stern H; Expert Panel on Thoracic Surgical Oncology. Standards for thoracic surgical oncology in a single-payer healthcare system. Ann Thorac Surg. 2007;84(2):693-701.